Related Experiment Video
Updated: Apr 1, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Breast feeding: preventive therapy for type 2 diabetes
Bharti Kalra1, Yashdeep Gupta2, Sanjay Kalra3
1Department of Obstetrics, Bharti Hospital & BRIDE, Karnal, India.
Exclusive breastfeeding for six months, with continued breastfeeding alongside complementary foods up to two years and beyond, is recommended. This practice may help prevent type 2 diabetes in mothers and type 1 diabetes and obesity in children.
Area of Science:
- Endocrinology
- Public Health
- Pediatrics
Background:
- The World Health Organization recommends exclusive breastfeeding for six months, continuing with complementary feeding up to two years and beyond.
- Breastfeeding offers numerous health benefits, including potential prevention of metabolic disorders.
Purpose of the Study:
- To review the evidence linking breastfeeding to type 2 diabetes prevention in mothers.
- To highlight breastfeeding management strategies for optimizing its preventive role.
Main Methods:
- Literature review of studies on breastfeeding and type 2 diabetes.
- Analysis of breastfeeding practices and their impact on maternal and child metabolic health.
Main Results:
- Evidence suggests breastfeeding may reduce the risk of type 2 diabetes and metabolic syndrome in mothers.
- Breastfeeding is associated with a lower incidence of type 1 diabetes, overweight, and obesity in offspring.
Conclusions:
- Breastfeeding is a natural intervention with significant potential for preventing type 2 diabetes in mothers.
- Optimizing breastfeeding management can enhance its role in metabolic disease prevention for both mothers and children.
More Related Videos
05:04A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
Published on: September 22, 2023
06:27Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...